Skip to main content
. Author manuscript; available in PMC: 2022 Oct 25.
Published in final edited form as: Invest New Drugs. 2018 Aug 31;37(2):307–314. doi: 10.1007/s10637-018-0662-1

Table 2.

Patient Characteristics

Overall (N=27) Cohort I (N=15) Cohort II (N=12)

Age, median(range) 59 (25,80) 47 (25,80) 65 (46,75)
Gender
 Female 18 (66.7%) 11 (73.3%) 7 (58.3%)
 Male 9 (33.3%) 4 (26.7%) 5 (41.7%)
Race
 White 27 (100%) 15 (100%) 12 (100%)
Performance Score
 0 16 (59.3%) 11 (73.3%) 5 (41.7%)
 1 11 (40.7%) 4 (26.7%) 7 (58.3%)
Prior Treatments
 Chemotherapy 21 (77.8%) 10 (66.7%) 11 (91.7%)
 Radiation Therapy 14 (51.9%) 6 (40%) 8 (66.7%)
 Surgery 27 (100%) 15 (100%) 12 (100%)